Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Zhiyi Pharmaceutics
About
Zhiyi Pharmaceutics focuses on the research and development of second-generation probiotics and Live Biotherapeutics.
- Guangzhou,Guangdong,China
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥50M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- 广州知易生物科技有限公司
Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 4, 2022 | Series B | ¥300M | 1 | — | — | Detail |
| Sep 22, 2021 | Series B | — | 1 | — | — | Detail |
| Dec 23, 2020 | Series B | ¥110M | 3 | — | — | Detail |
| Sep 5, 2018 | Series A | ¥50M | 3 | — | — | Detail |
| Sep 6, 2017 | Angel | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SDIC Venture Capital
|
— | Series B |
Kingsum Capital
|
— | Series B |
|
|
— | Series B |
Korea Investment Holdings
|
— | Series B |
|
|
— | Series A |
|
|
— | Series A |
Shenzhen Capital Group
|
— | Series A |
Hejun Capital
|
— | Angel |
